|
CCNG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.77315972805081E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.88098491916389E-15 |
| Normal-vs-Stage2 |
6.06650000012365E-07 |
| Normal-vs-Stage3 |
2.84830004027015E-09 |
| Normal-vs-Stage4 |
1.68310000003835E-06 |
| Stage1-vs-Stage2 |
2.451000E-01 |
| Stage1-vs-Stage3 |
7.168800E-01 |
| Stage1-vs-Stage4 |
7.452800E-01 |
| Stage2-vs-Stage3 |
1.393970E-01 |
| Stage2-vs-Stage4 |
5.348200E-01 |
| Stage3-vs-Stage4 |
5.466200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.54871728961371E-15 |
| Normal-vs-AfricanAmerican |
1.13530000001028E-06 |
| Normal-vs-Asian |
1.74642999999364E-05 |
| Caucasian-vs-AfricanAmerican |
1.607400E-01 |
| Caucasian-vs-Asian |
8.674400E-01 |
| AfricanAmerican-vs-Asian |
5.749000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0547118733939E-14 |
| Normal-vs-Female |
2.52119991550614E-10 |
| Male-vs-Female |
1.348980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.06109999997717E-06 |
| Normal-vs-Extreme_Weight |
1.62481139653892E-12 |
| Normal-vs-Obese |
1.49890100331618E-11 |
| Normal-vs-Extreme_Obese |
1.06560000046052E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.490400E-01 |
| Normal_Weight-vs-Obese |
6.257000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.714200E-01 |
| Extreme_Weight-vs-Obese |
3.381700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.696400E-01 |
| Obese-vs-Extreme_Obese |
3.463000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.44220000070683E-08 |
| Normal-vs-Age(41-60Yrs) |
9.1970875359948E-13 |
| Normal-vs-Age(61-80Yrs) |
3.47499806707674E-14 |
| Normal-vs-Age(81-100Yrs) |
5.97209948161037E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.327200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.081600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.852800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.823800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.212970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.139000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
6.7612582199672E-14 |
| Normal-VS-KIRP CIMP |
9.99959999999911E-05 |
| Normal-VS-Unclassified PRCC |
1.82839999807172E-08 |
| Type1 PRCC-VS-Type2 PRCC |
6.410200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.638400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.404000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.499000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.107200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.473800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
1.09350000165875E-08 |
| Normal-vs-N2 |
1.795920E-04 |
| N0-vs-N1 |
2.542000E-01 |
| N0-vs-N2 |
7.827400E-01 |
| N1-vs-N2 |
8.005000E-01 |
|
|
